Serina Therapeutics (SER) Current Leases (2019 - 2024)

Serina Therapeutics has disclosed Current Leases across 4 years of filings, most recently posting $200000.0 for Q2 2024.

• In Q2 2024, Current Leases changed N/A year-over-year to $200000.0; the TTM figure through Jun 2024 stood at $200000.0 (changed N/A YoY), while the FY2023 annual figure was $214000.0, changed N/A from the prior year.
• Current Leases came in at $200000.0 for Q2 2024 at Serina Therapeutics, down from $207000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $325000.0 in Q1 2020 to a low of $109000.0 in Q3 2020.
• Average Current Leases over 3 years is $212166.7, with a median of $210500.0 recorded in 2023.
• The largest YoY upside for Current Leases was 46.44% in 2020 against a maximum downside of 73.86% in 2020.
• Over 3 years, Current Leases stood at $109000.0 in 2020, then soared by 96.33% to $214000.0 in 2023, then fell by 6.54% to $200000.0 in 2024.
• Per Business Quant data, the three most recent Current Leases figures were $200000.0 in Q2 2024, $207000.0 in Q1 2024, and $214000.0 in Q4 2023.